Breath-actuated inhalers: comparison of terbutaline Turbohaler with salbutamol Rotahaler
- 30 June 1989
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 2 (7) , 640-642
- https://doi.org/10.1183/09031936.93.02070640
Abstract
Two breath-actuated inhalers, the Turbohaler and the Rotahaler, were compared in 24 patients with chronic asthma using an open, cross-over study design. Patients were treated with terbutaline (500 micrograms) and salbutamol (400 micrograms) four times daily, each trial period lasting three weeks. Mean morning peak expiratory flow (PEF) values were higher during Turbohaler treatment, but were similar 15 min after inhaler use. The Turbohaler was found to be easier to use than the Rotahaler.This publication has 1 reference indexed in Scilit:
- Comparison of inhaled salbutamol powder and aerosol in asthmatic patients with low peak expiratory flow levelEuropean Journal of Clinical Pharmacology, 1985